1
|
Rodríguez-Piñón M, Casuriaga D, García-Barcelo G, Fila D, Gil J. Increasing cervical penetrability in sheep by long-acting treatments with oxytocin (Carbetocin) and/or prostaglandin E2 (Dinoprostone). Domest Anim Endocrinol 2025; 91:106920. [PMID: 39933278 DOI: 10.1016/j.domaniend.2025.106920] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/24/2024] [Revised: 02/07/2025] [Accepted: 02/07/2025] [Indexed: 02/13/2025]
Abstract
The aim was to study the effect of long-acting treatments with oxytocin (Carbetocin, Cb) and/or prostaglandin E2 (Dinoprostone, Dp) on cervical penetrability and collagenolysis in synchronized ewes (12 days MAP-eCG). At 42 h post eCG, ewes were treated with Cb (Group Cb, n = 6, 40 μg, i.m., Decomotón, Laboratorios Callier, Uruguay); Dp (Group Dp, n = 10, 10 mg, slow-release intravaginal device, Propess®, Ferring Pharmaceuticals Ltd., West Drayton, UK); combined Cb and Dp treatment (Group Cb+Dp, n = 8) and saline solution i.m. and a placebo intravaginal device (Group C, n = 10). Cervical penetrability increased from 0 h to 42 h post eCG (P < 0.003) in all groups, then decrease in Group C (P < 0.03) from 42 to 68 h post eCG, whereas remained unchanged in Groups Cb and Cb+Dp or increase at 54 h post eCG in Group Dp (P < 0.05). Thus, there was higher cervical penetrability in treated groups than Group C at the expected time of artificial insemination (54 h post eCG). At 54 h post eCG, collagen concentration was lower in Group Cb than in the others groups (P < 0.05), whereas the ratio between the activity of the activated and latent forms of MMP-2 was greater in Groups Cb and Cb+Dp than in Group C (P < 0.05). The increasing cervical penetrability induced by Cb, but not by Dp, could be explained by an increase in MMP-2-dependent collagen degradation. Furthermore, combined treatment with Cb and Dp did not enhance the effects induced by each hormone administered separately.
Collapse
Affiliation(s)
- M Rodríguez-Piñón
- Biochemistry, Veterinary Biosciences Department, Veterinary Faculty, Universidad de la República, Ruta 8, Km 18 y Ruta 102, 13000, Montevideo, Uruguay.
| | - D Casuriaga
- Biochemistry, Veterinary Biosciences Department, Veterinary Faculty, Universidad de la República, Ruta 8, Km 18 y Ruta 102, 13000, Montevideo, Uruguay
| | - G García-Barcelo
- Biochemistry, Veterinary Biosciences Department, Veterinary Faculty, Universidad de la República, Ruta 8, Km 18 y Ruta 102, 13000, Montevideo, Uruguay
| | - D Fila
- Animal Reproduction, Animal Production Department, Veterinary Faculty, Universidad de la República, Ruta 8, Km 18 y Ruta 102, 13000, Montevideo, Uruguay
| | - J Gil
- Animal Reproduction Laboratory, Biological Sciences Department, Centro Universitario Regional Litoral Norte, Universidad de la República, Estación Experimental Mario A. Cassinoni, R3, km 363, 57072/60000, Paysandú, Uruguay
| |
Collapse
|
2
|
Pedro GB, Angel R, Marcelo RP, Hugo C. In vitro study of carbetocin, an oxytocin receptor agonist, and 4-phenylfuroxan-3-carbonitrile, a NO-releasing agent, as cervical dilatators in sheep. Theriogenology 2025; 235:168-174. [PMID: 39842222 DOI: 10.1016/j.theriogenology.2025.01.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/02/2024] [Revised: 01/04/2025] [Accepted: 01/05/2025] [Indexed: 01/24/2025]
Abstract
The aim was to study the effect of 4-phenylfuroxan-3-carbonitrile (Fx), a NO-releasing agent, and carbetocin, an oxytocin receptor agonist, on matrix metalloproteinases-2 (MMP-2) activity and PGE2 production in cervix from cycling sheep. Cervical explants were incubated during 12 h with MEM supplemented with increasing concentrations of Fx in DMSO (2 %) (0 to 300 μg/mL) with Cb (100 ng/mL) (Experiment 1, n = 15) and DMSO (2 %), DMSO + Cb (100 ng/mL) or DMSO + Fx (30 μg/mL) (Experiment 2, n = 10), and their respective controls. In the supernatants, activated (A) and latent (L) MMP-2 activities were determined by a SDS-PAGE zymography, PGE2 concentration by immunoassay and NO production indirectly as nitrites by spectrophotometry. Data were analyzed by ANOVA. The Cb treatment increase the A MMP-2 activity in DMSO (Experiment 1 at follicular phase and Experiment 2) or alone (Experiment 2) and increase the L MMP-2 activity (Experiments 1 and 2) (P < 0.02). The DMSO treatment also increase the L MMP2 activity (Experiment 2) (P < 0.0001). Treatment with Fx + DMSO increased the concentration of accumulated nitrites in the supernatant (P < 0.0001) (Experiment 1), but did not affect or decrease the activity of A and L MMP-2 (P < 0.04) (Experiments 1 and 2). The PGE2 concentration trend to increase with Cb treatment (P = 0.0614) and decrease with Fx+DMSO treatment (P < 0.0001) (Experiment 2). In conclusion, Cb and/or DMSO treatment of cervical explants increase the MMP-2 activity through PGE2-independent mechanisms, but Fx in DMSO fail in this, suggesting that the pre-treatment with Cb and/or DMSO could be used to increase cervical dilation in ewes.
Collapse
Affiliation(s)
- García-Barcelo Pedro
- Unidad de Bioquímica, Departamento de Biociencias Veterinarias, Facultad de Veterinaria, Universidad de la República, Ruta 8, Km 18 y Ruta 102, 13000, Montevideo, Uruguay
| | - Romero Angel
- Grupo de Química Orgánica Medicinal, Instituto de Química Biológica, Facultad de Ciencias, Universidad de la República, Iguá 4225, 11400, Montevideo, Uruguay
| | - Rodríguez-Piñón Marcelo
- Unidad de Bioquímica, Departamento de Biociencias Veterinarias, Facultad de Veterinaria, Universidad de la República, Ruta 8, Km 18 y Ruta 102, 13000, Montevideo, Uruguay.
| | - Cerecetto Hugo
- Grupo de Química Orgánica Medicinal, Instituto de Química Biológica, Facultad de Ciencias, Universidad de la República, Iguá 4225, 11400, Montevideo, Uruguay; Área de Radiofarmacia, Centro de Investigaciones Nucleares, Facultad de Ciencias, Universidad de la República, Mataojo 2055, 11400, Montevideo, Uruguay.
| |
Collapse
|
3
|
Rodríguez-Piñón M, García-Barcelo G. Increasing matrix metalloproteinase-2 activity by treatment of ovine cervical explants with a long-acting analogue of oxytocin (Carbetocin) at the expected time of artificial insemination. Vet Res Commun 2025; 49:85. [PMID: 39841327 DOI: 10.1007/s11259-025-10652-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/28/2024] [Accepted: 01/15/2025] [Indexed: 01/23/2025]
Abstract
The aim was to study the effect of long-acting analogue of oxytocin (Carbetocin) on cervical collagenolysis of MAP-eCG synchronized ewes. At the expected time of artificial insemination, five ewes were slaughtered (n = 5) and their cervical explants (100-200 mg) were incubated during 12 h with MEM supplemented with 0, 8, 16, 32 and 64 ng/mL of Cb. Activities of activated and latent forms of matrix metalloproteinases-2 and - 9 (MMP-2 and MMP-9, respectively) in the supernatant were determined by a SDS-PAGE zymography and prostaglandin E2 concentration by immunoassay. Data were analyzed by ANOVA test. The MMP-9 activity was detected weakly and sporadically. The activity of activated MMP-2 was higher in 32 ng/mL Carbetocin treated samples than in untreated samples (P < 0.03). The activity of latent MMP-2 tended to be higher in 32 ng/mL than in 8 ng/mL Carbetocin treated samples (P = 0.083). The activated/latent ratio of MMP-2 tended to be higher in 64 ng/mL Cb treated samples than in untreated samples (P = 0.089). Prostagladin E2 concentration was not affected by Carbetocin dose. The data show that Carbetocin treatment of cervical explants induces an increase in MMP-2 activity by prostaglandin E2-independent mechanisms, suggesting Carbetocin as a potential inducer of cervical dilation in sheep.
Collapse
Affiliation(s)
- Marcelo Rodríguez-Piñón
- Biochemistry, Veterinary Biosciences Department, Veterinary Faculty, Universidad de la República, Ruta 8, Km 18 y Ruta 102, Montevideo, 13000, Uruguay.
| | - Gonzalo García-Barcelo
- Biochemistry, Veterinary Biosciences Department, Veterinary Faculty, Universidad de la República, Ruta 8, Km 18 y Ruta 102, Montevideo, 13000, Uruguay
| |
Collapse
|
4
|
Shi JW, Lai ZZ, Yang HL, Yang SL, Wang CJ, Ao D, Ruan LY, Shen HH, Zhou WJ, Mei J, Fu Q, Li MQ. Collagen at the maternal-fetal interface in human pregnancy. Int J Biol Sci 2020; 16:2220-2234. [PMID: 32549767 PMCID: PMC7294936 DOI: 10.7150/ijbs.45586] [Citation(s) in RCA: 47] [Impact Index Per Article: 9.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/03/2020] [Accepted: 05/15/2020] [Indexed: 02/07/2023] Open
Abstract
The survival and development of a semi-allogenic fetus during pregnancy require special immune tolerance microenvironment at the maternal fetal interface. During the establishment of a successful pregnancy, the endometrium undergoes a series of changes, and the extracellular matrix (ECM) breaks down and remodels. Collagen is one of the most abundant ECM. Emerging evidence has shown that collagen and its fragment are expressed at the maternal fetal interface. The regulation of expression of collagen is quite complex, and this process involves a multitude of factors. Collagen exerts a critical role during the successful pregnancy. In addition, the abnormal expressions of collagen and its fragments are associated with certain pathological states associated with pregnancy, including recurrent miscarriage, diabetes mellitus with pregnancy, preeclampsia and so on. In this review, the expression and potential roles of collagen under conditions of physiological and pathological pregnancy are systematically discussed.
Collapse
Affiliation(s)
- Jia-Wei Shi
- NHC Key Lab of Reproduction Regulation (Shanghai Institute of Planned Parenthood Research), Hospital of Obstetrics and Gynecology, Fudan University, Shanghai 200080, People's Republic of China.,Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases, Hospital of Obstetrics and Gynecology, Fudan University, Shanghai 200080, People's Republic of China
| | - Zhen-Zhen Lai
- Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases, Hospital of Obstetrics and Gynecology, Fudan University, Shanghai 200080, People's Republic of China
| | - Hui-Li Yang
- Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases, Hospital of Obstetrics and Gynecology, Fudan University, Shanghai 200080, People's Republic of China
| | - Shao-Liang Yang
- Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases, Hospital of Obstetrics and Gynecology, Fudan University, Shanghai 200080, People's Republic of China
| | - Cheng-Jie Wang
- Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases, Hospital of Obstetrics and Gynecology, Fudan University, Shanghai 200080, People's Republic of China
| | - Deng Ao
- Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases, Hospital of Obstetrics and Gynecology, Fudan University, Shanghai 200080, People's Republic of China
| | - Lu-Yu Ruan
- Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases, Hospital of Obstetrics and Gynecology, Fudan University, Shanghai 200080, People's Republic of China
| | - Hui-Hui Shen
- Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases, Hospital of Obstetrics and Gynecology, Fudan University, Shanghai 200080, People's Republic of China
| | - Wen-Jie Zhou
- Center of Reproductive Medicine of Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, People's Republic of China
| | - Jie Mei
- Reproductive Medicine Center, Department of Obstetrics and Gynecology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu 210008, People's Republic of China
| | - Qiang Fu
- Department of Immunology, Binzhou Medical College, Yantai, 264003, People's Republic of China
| | - Ming-Qing Li
- NHC Key Lab of Reproduction Regulation (Shanghai Institute of Planned Parenthood Research), Hospital of Obstetrics and Gynecology, Fudan University, Shanghai 200080, People's Republic of China.,Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases, Hospital of Obstetrics and Gynecology, Fudan University, Shanghai 200080, People's Republic of China
| |
Collapse
|